SEC Form 4 · accession 0001070081-17-000053
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Rothera
Officer — Chief Commercial Officer
Period of report
Feb 16, 2017
Accepted (ET)
Feb 17, 2017 · 6:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 16, 2017 | M | 3,125 | $10.85 | A | 28,773 | D | |
| Common StockF1 | holding | — | — | — | 9,216 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right To Buy)F2 | $10.85 | Feb 16, 2017 | M | 3,125 | D | — | May 15, 2023 | Common Stock | 3,125 | 72,193 | D |
| Stock Option (Right To Buy)F3 | $10.85 | holding | — | — | — | — | May 15, 2023 | Common Stock | 8,125 | 8,125 | D |
| Stock Option (Right To Buy)F4 | $27.05 | holding | — | — | — | — | Jan 27, 2024 | Common Stock | 65,000 | 65,000 | D |
| Stock Option (Right To Buy)F5 | $51.00 | holding | — | — | — | — | Jan 1, 2025 | Common Stock | 69,550 | 69,550 | D |
| Stock Option (Right To Buy)F6 | $30.86 | holding | — | — | — | — | Jan 3, 2026 | Common Stock | 70,000 | 70,000 | D |
| Stock Option (Right To Buy)F7 | $11.23 | holding | — | — | — | — | Jan 2, 2027 | Common Stock | 56,000 | 56,000 | D |
Explanation of responses
- F1Shares held by trust of which reporting person's spouse is a beneficiary and co-trustee.
- F2This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 15, 2014.
- F3This option was granted on May 15, 2013 and vests as follows: 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on January 31, 2014.
- F4This option was granted on January 28, 2014, and vests over four years, with 25% of the shares underlying the option vested on January 1, 2015, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2015.
- F5This option was granted on January 2, 2015, and vests over four years, with 25% of the shares underlying the option vested on January 1, 2016, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2016.
- F6This option was granted on January 4, 2016, and vests over four years, with 25% of the shares underlying the option vesting on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017.
- F7This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.